Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock.

× No keyword cloud information.

7 in total

1. More on pathogenesis and treatment of septic shock.

Authors: D Fumarola; S Pece
Journal: Eur J Epidemiol Date: 1992-09 Impact factor: 8.082

Review 2. Sepsis and septic shock. II. Treatment.

Authors: J Mayer; R Hajek; J Vorlicek; M Tomiska
Journal: Support Care Cancer Date: 1995-03 Impact factor: 3.603

3. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.

Authors: S J De Kimpe; C Thiemermann; J R Vane
Journal: Br J Pharmacol Date: 1995-12 Impact factor: 8.739

4. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase.

Authors: C C Silliman; K L Clay; G W Thurman; C A Johnson; D R Ambruso
Journal: J Lab Clin Med Date: 1994-11

5. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.

Authors: S Yamanaka; H Iwao; T Yukimura; S Kim; K Miura
Journal: Br J Pharmacol Date: 1993-12 Impact factor: 8.739

6. Are events after endotoxemia related to circulating phospholipase A2?

Authors: A A Santos; J L Browning; M R Scheltinga; E A Lynch; E F Brown; P Lawton; E Chambers; I Dougas; C D Benjamin; C A Dinarello
Journal: Ann Surg Date: 1994-02 Impact factor: 12.969

7. Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis.

Authors: L W Torley; W C Pickett; M L Carroll; C A Kohler; R E Schaub; A Wissner; S Q DeJoy; A L Oronsky; S S Kerwar
Journal: Antimicrob Agents Chemother Date: 1992-09 Impact factor: 5.191

7 in total